ADRA1D
Alpha-1D adrenergic receptor
Also known as: ADA1D_HUMAN, ADRA1, ADRA1A, ADRA1R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P25100
- Gene
- ADRA1D
- Ensembl
- ENSG00000171873
- Chromosome
- 20
- Canonical length
- 572 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1D-adrenergic receptor. Similar to alpha-1B-adrenergic receptor gene, this gene comprises 2 exons and a single intron that interrupts the coding region. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
572 residues, UniProt reviewed canonical sequence.
>P25100|ADRA1D
1 MTFRDLLSVS FEGPRPDSSA GGSSAGGGGG SAGGAAPSEG PAVGGVPGGA GGGGGVVGAG
61 SGEDNRSSAG EPGSAGAGGD VNGTAAVGGL VVSAQGVGVG VFLAAFILMA VAGNLLVILS
121 VACNRHLQTV TNYFIVNLAV ADLLLSATVL PFSATMEVLG FWAFGRAFCD VWAAVDVLCC
181 TASILSLCTI SVDRYVGVRH SLKYPAIMTE RKAAAILALL WVVALVVSVG PLLGWKEPVP
241 PDERFCGITE EAGYAVFSSV CSFYLPMAVI VVMYCRVYVV ARSTTRSLEA GVKRERGKAS
301 EVVLRIHCRG AATGADGAHG MRSAKGHTFR SSLSVRLLKF SREKKAAKTL AIVVGVFVLC
361 WFPFFFVLPL GSLFPQLKPS EGVFKVIFWL GYFNSCVNPL IYPCSSREFK RAFLRLLRCQ
421 CRRRRRRRPL WRVYGHHWRA STSGLRQDCA PSSGDAPPGA PLALTALPDP DPEPPGTPEM
481 QAPVASRRKP PSAFREWRLL GPFRRPTTQL RAKVSSLSHK IRAGGAQRAE AACAQRSEVE
541 AVSLGVPHEV AEGATCQAYE LADYSNLRET DILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADRA1D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 6.6 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 6.6 nTPM
- hippocampal formation: 6.1 nTPM
- cervix: 5.8 nTPM
- endometrium: 3 nTPM
- prostate: 3 nTPM
- vagina: 2.6 nTPM
Single-cell type
- epicardial cells: 48 nCPM
- pericytes: 10 nCPM
- vascular smooth muscle cells: 10 nCPM
- brain inhibitory neurons: 3.5 nCPM
- brain excitatory neurons: 3.1 nCPM
- hematopoietic stem cells: 2.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 23 nTPM
- hippocampal formation: 19 nTPM
- amygdala: 13 nTPM
- cerebral cortex: 13 nTPM
- midbrain: 12 nTPM
- hypothalamus: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating adrenergic receptor signaling pathway
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- cell-cell signaling
- G protein-coupled receptor signaling pathway
- neuron-glial cell signaling
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of cell population proliferation
- positive regulation of cytosolic calcium ion concentration
- positive regulation of MAPK cascade
- positive regulation of vasoconstriction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADRA1D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADRA1D as an antibody target. Whether an autoantibody or antibody against ADRA1D could matter depends on whether native ADRA1D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADRA1D is annotated at the cell surface, where native ADRA1D is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADRA1D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...